Zur, and Jorge Andres Vizcaino-Riveros, examines 17 years of implementation research (20072023) funded by The National Institute on Drug Abuse (NIDA)
The authors used target trial emulation to compare rates of allopurinol initiation and use of anti-inflammatories (high-dose glucocorticoids, nonsteroidal anti-inflammatory drugs [NSAIDs], colchicine) and diuretics (prototypic serum urate-raising medication) among patients with gout using SGLT2is versus dipeptidyl peptidase 4 inhibitors (DPP-4is) (primary comparator), with GLP-1RAs as an alternative comparator
Sultan, Vitalogy focuses on non traditional, whole body wellness strategies that blend aesthetics, longevity, and regenerative support to help patients feel their best at any stage of life
therefore, randomized trials are still awaited
We dont take word of mouth for quality
The primary strength of this meta-analysis lies in its novelty and methodological rigor